Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Revised PORT recommendations.
Stroup TS, McEvoy JP, Lieberman JA. Stroup TS, et al. Among authors: mcevoy jp. Schizophr Bull. 2004;30(3):609-11. doi: 10.1093/oxfordjournals.schbul.a007106. Schizophr Bull. 2004. PMID: 15631251 No abstract available.
Results of phase 3 of the CATIE schizophrenia trial.
Stroup TS, Lieberman JA, McEvoy JP, Davis SM, Swartz MS, Keefe RS, Miller AL, Rosenheck RA, Hsiao JK; CATIE Investigators. Stroup TS, et al. Among authors: mcevoy jp. Schizophr Res. 2009 Jan;107(1):1-12. doi: 10.1016/j.schres.2008.10.011. Epub 2008 Nov 21. Schizophr Res. 2009. PMID: 19027269 Free PMC article. Clinical Trial.
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA. Stroup TS, et al. Among authors: mcevoy jp. Schizophr Bull. 2003;29(1):15-31. doi: 10.1093/oxfordjournals.schbul.a006986. Schizophr Bull. 2003. PMID: 12908658 Clinical Trial.
The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe RS, Stroup TS, Lieberman JA. Meyer JM, et al. Among authors: mcevoy jp. Schizophr Res. 2005 Dec 1;80(1):9-18. doi: 10.1016/j.schres.2005.07.015. Epub 2005 Aug 24. Schizophr Res. 2005. PMID: 16125372 Clinical Trial.
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.
McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Scott Stroup T, Lieberman JA. McEvoy JP, et al. Schizophr Res. 2005 Dec 1;80(1):19-32. doi: 10.1016/j.schres.2005.07.014. Epub 2005 Aug 30. Schizophr Res. 2005. PMID: 16137860
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators. Stroup TS, et al. Among authors: mcevoy jp. Am J Psychiatry. 2006 Apr;163(4):611-22. doi: 10.1176/ajp.2006.163.4.611. Am J Psychiatry. 2006. PMID: 16585435 Clinical Trial.
240 results